These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25265245)

  • 1. Imaging of inflammatory reactions.
    Signore A
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):235-6. PubMed ID: 25265245
    [No Abstract]   [Full Text] [Related]  

  • 2. Imaging T-lymphocytes in inflammatory diseases: a nuclear medicine approach.
    Malviya G; Galli F; Sonni I; Signore A
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):237-57. PubMed ID: 25265246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPECT radiopharmaceuticals for imaging chronic inflammatory diseases in the last decade.
    Anzola LK; Galli F; Dierckx RA
    Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):197-213. PubMed ID: 25669765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging B lymphocytes in autoimmune inflammatory diseases.
    Iodice V; Laganà B; Lauri C; Capriotti G; Germano V; D'Amelio R; Picchianti Diamanti A
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):258-68. PubMed ID: 25265247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting monocytes and macrophages by means of SPECT and PET.
    Van De Wiele C; Sathekge M; Maes A
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):269-75. PubMed ID: 24844256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cardiovascular imaging is ready for prime time: almost there.
    Sadeghi MM
    J Nucl Cardiol; 2016 Feb; 23(1):67-70. PubMed ID: 26542993
    [No Abstract]   [Full Text] [Related]  

  • 7. Debate: Molecular cardiac imaging is ready for the prime time con between wishful thinking and reality.
    Carrió I
    J Nucl Cardiol; 2016 Feb; 23(1):64-6. PubMed ID: 26542992
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiotracer Imaging of Peripheral Vascular Disease.
    Stacy MR; Zhou W; Sinusas AJ
    J Nucl Med Technol; 2015 Sep; 43(3):185-92. PubMed ID: 26338845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor targeting agents for imaging inflammation/infection: where are we now?
    Signore A; Chianelli M; D'Alessandria C; Annovazzi A
    Q J Nucl Med Mol Imaging; 2006 Sep; 50(3):236-42. PubMed ID: 16868537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular imaging of coronary inflammation: overcoming hurdles one at a time..
    Narula J; Chandrashekhar Y
    JACC Cardiovasc Imaging; 2010 Apr; 3(4):448-50. PubMed ID: 20394909
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukocyte receptor-binding radiopharmaceuticals for infection and inflammation scintigraphy.
    Tulchinsky M; Peters AM
    J Nucl Med; 2005 May; 46(5):718-21. PubMed ID: 15872341
    [No Abstract]   [Full Text] [Related]  

  • 12. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.
    Zhuang H; Pourdehnad M; Lambright ES; Yamamoto AJ; Lanuti M; Li P; Mozley PD; Rossman MD; Albelda SM; Alavi A
    J Nucl Med; 2001 Sep; 42(9):1412-7. PubMed ID: 11535734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear imaging to support anti-inflammatory drug discovery and development.
    Wunder A; Thiele A; Koslowski M; Gantner F; Niessen H
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):290-8. PubMed ID: 25265250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of infection and inflammation with 18F-FDG-labeled leukocytes.
    Rini JN; Palestro CJ
    Q J Nucl Med Mol Imaging; 2006 Jun; 50(2):143-6. PubMed ID: 16770304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restaging: should we percist without pattern recognition?
    Hofman MS; Hicks RJ
    J Nucl Med; 2010 Dec; 51(12):1830-2. PubMed ID: 21078792
    [No Abstract]   [Full Text] [Related]  

  • 16. [FDG PET for the localization diagnosis in inflammatory disease of unknown origin--two case reports].
    Weiner GM; Jenicke L; Buchert R; Bohuslavizki KH
    Nuklearmedizin; 2001 Aug; 40(4):N35-8. PubMed ID: 11556205
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and evaluation of l-5-(2-[(18)F]fluoroethoxy)tryptophan as a new PET tracer.
    Li R; Wu SC; Wang SC; Fu Z; Dang Y; Huo L
    Appl Radiat Isot; 2010 Feb; 68(2):303-8. PubMed ID: 19906535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabeled chemotactic cytokines: new agents for scintigraphic imaging of infection and inflammation.
    van Eerd JE; Boerman OC; Corstens FH; Oyen WJ
    Q J Nucl Med; 2003 Dec; 47(4):246-55. PubMed ID: 14973417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical PET in oncology.
    Biersack HJ; Bender H; Ruhlmann J; Oehr P; Guhlke S; Grünwald F
    Rev Esp Med Nucl; 2000 Jun; 19(3):219-24. PubMed ID: 11062087
    [No Abstract]   [Full Text] [Related]  

  • 20. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection.
    Jamar F; Buscombe J; Chiti A; Christian PE; Delbeke D; Donohoe KJ; Israel O; Martin-Comin J; Signore A
    J Nucl Med; 2013 Apr; 54(4):647-58. PubMed ID: 23359660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.